Tumor-necrosis-factor-induced fibroblast growth factor-1 acts as a survival factor in a transformed endothelial cell line

American Journal of Pathology

Volumn 149, Issue 3, 1996, Pages 945-952

  Maier, Jeanette A M ^a   Morelli, Daniele ^b   Ménard, Sylvie ^b   Colnaghi, Maria I ^b   Balsari, Andrea ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FIBROBLAST GROWTH FACTOR 1; PROTEIN BCL 2; RECOMBINANT TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

APOPTOSIS; BASE SEQUENCE; CELL DIVISION; CELL LINE, TRANSFORMED; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; UP-REGULATION;

EID: 0029747038     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Laster SM, Wood JG, Gooding LR: Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 1988, 141:2629-2634
2. Hofmockel G, Bassukas ID, Heimbach D, Metz R, Wirth MP: The effect of tumor necrosis factor-α on a human renal cell carcinoma xenotransplanted into nude mice: comparison of intravenous and intraperitoneal injection. Oncology 1995, 52:69-75
3. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975, 72:3666-3670
4. Mantovani A, Bussolino F, Dejana E: Cytokine regulation of endothelial cell function. FASEB J 1992, 6:2591-2599
5. Shimomura K, Manda T, Mukumoto S, Kobayashi K, Nakano K, Mori J: Recombinant human tumor necrosis factor-α: thrombus formation is a cause of anti-tumor activity, Int J Cancer 1988, 41:243-247
6. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P: Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 1991, 138:447-453
7. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB: Induction of endothelial cell apoptosis by TNF-α: modulation by inhibitors of protein synthesis. Exp Cell Res 1994, 214:584-594
8. Frater-Schröder M, Riseau W, Hallmann R, Gantschi P, Böhlen P: Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987, 84:5277-5281
9. Fajardo L: The complexity of endothelial cells. Am J Clin Pathol 1989, 92:241-250
10. Chan HY, Harris AL: Gene therapy targeting to tumor endothelium. The Internet Book of Gene Therapy: Cancer Therapeutics. Edited by RE Sobol, K Scanlon. Stamford, CT, Appleton & Lange, 1995, 21 pp 211-227
11. Wang JM, Kumar S, Pye D, Van Agthoven AJ, Krupinski J, Hunter RD: A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues, Int J Cancer 1993, 54:363-370
12. Anagnostopoulos ID, Kaklamanis L, Cordell J, Jones M, Turley H, Pulford K, Simmons D, Mason D, Gatter K: ICAM-3 expression on endothelium in lymphoid malignancy. Am J Pathol 1993, 143:1040-1043
13. Maier JAM, Statuto M, Ragnotti G: Endogenous interleukin-1α must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 1994, 14:1845-1851
14. Takahashi K, Sawasaki Y, Hato J, Mukai K, Goto T: Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990, 25: 265-274
15. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
16. Maier JAM, Morelli D, Balsari A: The differential response to interferon-γ by normal and transformed endothelial cells. Biochem Biophys Res Commun 1995, 214:582-588
17. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
18. Maier JAM, Voulalas P, Roeder D, Maciag T: Antisense interleukin-1α oligomer extends the lifespan of the human endothelial cell in vitro. Science 1990, 249:1570-1574
19. Sano H, Forough R, Maier JAM, Case JP, Jackson A, Engleka K, Maciag T, Wilder R: High level expression of heparin binding growth factor-1 (acidic FGF) in inflammatory joints. J Cell Biol 1990, 110:1417-1426
20. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989, 58:576-606
21. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462
22. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 1991, 65:1097-1098
23. Kerr KM, Lamb D: A suggested explanation for the paradoxically slow rate of growth of basal carcinomas that contain numerous mitotic figures. J Pathol 1984, 107:41-50
24. Allan DJ, Howell A, Roberts SA, Williams GT, Watson RJ, Coyne JD, Clarke RB, Laidlaw IJ, Potten CS: Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 1992, 167:25-32
25. Araki S, Shimada Y, Kaji K, Hayashi H: Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 1990, 168:1194-1200
26. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F: Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994, 127:537-546
27. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267:10931-10934
28. Kondo S, Yin D, Aoki T, Takahashi JA, Morimura T, Takeuchi J: Bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp Cell Res 1994, 213:428-432
29. Tsukada T, Eguchi K, Migita K, Kiwabe Y, Kawakami A, Matsuoka N, Takashima H, Mizokami A, Nagataki S: Transforming growth factor-β1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun 1995, 210:1076-1082
30. Varani J, Dame MK, Taylor CG, Sarma V, Merino R, Kunkel RG, Nunez G, Dixit VM: Age-dependent injury in human umbilical vein endothelial cells: relationship to apoptosis and correlation with a lack of A20 expression. Lab Invest 1995, 73:851-858
31. Vanhaesebroeck B, Reed JC, De Valck D, Grooten G, Miyashita T, Tanaka S, Beyaert R, Van Roy F, Fiers W: Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene 1993, 8:1075-1081
32. Battegay EJ, Raines EW, Colbert T, Ross R: TNF-α stimulation of fibroblast proliferation. J Immunol 1995, 154:6040-6047
33. Woodworth CD, McMullin E, Iglesias M, Plowman GD: Interleukin 1α and tumor necrosis factor-α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA 1995, 92:2840-2844
34. Gay CG, Winkles JA: Interleukin 1 regulates heparin-binding growth factor 2 expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1991, 88:296-300
35. Tamm I, Kikuchi T, Zychlinsky A: Fibroblast growth factor: expression in cultured cells derived from corneal endothelium and lens epithelium. Proc Natl Acad Sci USA 1991, 88:3372-3376
36. Wilcox BJ, Unnerstall JR: Expression of acidic fibroblast growth factor mRNA in the developing and adult rat brain. Neuron 1991, 6:397-409
37. Jackson A, Friedman S, Zhan X, Engleka KA, Forough R, Maciag T: Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci USA 1992, 89:10691-10695
38. Opalenik SR, Shin JT, Wehby JN, Mahesh VK, Thompson JA: The HIV-1 TAT protein induces the expression and extracellular appearance of acid fibroblast growth factor. J Biol Chem 1995, 270:17457-17467
39. Imamura T, Engleka K, Zhan X, Tokita Y, Forough R, Roeder D1 Jackson A, Maier JAM, Hla T, Maciag T: Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 1990, 249:1569-1570
40. Renaud F, Oliver L, Desset S, Tassin J, Romquin N, Courtois Y, Laurent M: Up-regulation of aFGF expression in quiescent cells is related to cell survival. J Cell Physiol 1994, 158:435-443
41. Schlingermann RO, Rietveld FJR, Kwaspen F, Van de Kerkhof PCM, De Waal RMW, Ruiter DJ: Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 1991, 138:1335-1347
42. Watanabe N, Yamauchi N, Maeda M, Neda H, Okamoto T, Tsuji N, Akiyama S, Sasaki H, Niitsu Y: Recombinant human tumor necrosis factor causes regression in patients with advanced malignancies. Oncology 1994, 51:360-365